SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1446179 BALA CYNWYD, PA

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,257,716

+$796,895 QoQ

Shares Held

91,886

+45.6% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#147

of 555 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $18,967,826 across 42 Biotechnology names. BMRN ranks #1 (27.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc This page	91,886	$5,257,716
2	NKTR	Nektar Therapeutics	20,177	$1,408,556
3	QURE	uniQure N.V.	15,042	$692,834
4	OLMA	Olema Pharmaceuticals, Inc.	55,121	$689,563
5	VKTX	Viking Therapeutics, Inc.	16,620	$648,346
6	NTLA	Intellia Therapeutics, Inc.	37,663	$637,257
7	HRMY	Harmony Biosciences Holdings, Inc.	17,322	$630,694
8	IMNM	Immunome Inc.	26,035	$551,681

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,257,716	91,886	+45.6%	Shares	Sole	2026-08-14
2025-03-31	$4,460,821	63,104	-62.8%	Shares	Sole	2025-05-14
2024-12-31	$11,139,854	169,479	+148.0%	Shares	Sole	2025-02-14
2024-06-30	$5,626,926	68,346	+216.0%	Shares	Defined	2024-08-15
2023-03-31	$2,103,009	21,627	-46.7%	Shares	Defined	2023-05-16
2022-12-31	$4,201,280	40,596	-69.6%	Shares	Defined	2023-02-14
2022-09-30	$11,303,570	133,344	+271.3%	Shares	Defined	2022-11-14
2022-03-31	$2,768,661	35,910	+11.2%	Shares	Defined	2022-05-16
2021-12-31	$2,851,938	32,280	-60.1%	Shares	Defined	2022-02-14
2021-09-30	$6,247,350	80,830	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.